IL23A and psoriasis: Looking more closely at prominent psoriasis genes, a strong downregulation of IL-17-related genes (IL19, DEFB4, CCL20, LCN2, IL1B) and a less impressive but still significant reduction of IL-17A and IL-23 subunit genes were observed after treatment with both drugs.